Ayabudge LLC - May 25, 2023 Form 4 Insider Report for Humacyte, Inc. (HUMA)

Role
10%+ Owner
Signature
/s/ Ayabudge LLC by Dale A. Sander as Attorney-in-Fact
Stock symbol
HUMA
Transactions as of
May 25, 2023
Transactions value $
-$7,218,750
Form type
4
Date filed
5/26/2023, 05:02 PM
Previous filing
Dec 19, 2022
Next filing
Jun 15, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HUMA Common Stock Sale -$7.22M -2.63M -14.59% $2.75 15.4M May 25, 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On May 25, 2023, the Reporting Person sold 2,625,000 shares of Common Stock. The transactions enabled Mr. Brady W. Dougan, a person controlling the Reporting Person, to pay down leverage while providing a mechanism for the institutional healthcare investor purchasers to acquire shares of the Issuer at a time that the Issuer was not conducting a financing transaction and was not making any additional shares available for purchase.